Revolution Medicines Inc (RVMD) Shares Soar Above 1-Year High

Revolution Medicines Inc (NASDAQ: RVMD) has experienced a rise in its stock price by 1.52 compared to its previous closing price of 30.92. However, the company has seen a gain of 4.63% in its stock price over the last five trading days. Zacks Investment Research reported 2024-02-26 that Revolution Medicines, Inc. (RVMD) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to loss of $0.63 per share a year ago.

Is It Worth Investing in Revolution Medicines Inc (NASDAQ: RVMD) Right Now?

Company’s 36-month beta value is 1.54.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for RVMD is 136.41M, and currently, short sellers hold a 12.03% ratio of that floaft. The average trading volume of RVMD on April 04, 2024 was 1.36M shares.

RVMD’s Market Performance

The stock of Revolution Medicines Inc (RVMD) has seen a 4.63% increase in the past week, with a 6.41% rise in the past month, and a 11.19% gain in the past quarter. The volatility ratio for the week is 3.94%, and the volatility levels for the past 30 days are at 4.20% for RVMD. The simple moving average for the past 20 days is -0.54% for RVMD’s stock, with a 13.42% simple moving average for the past 200 days.

Analysts’ Opinion of RVMD

Many brokerage firms have already submitted their reports for RVMD stocks, with Piper Sandler repeating the rating for RVMD by listing it as a “Overweight.” The predicted price for RVMD in the upcoming period, according to Piper Sandler is $43 based on the research report published on March 11, 2024 of the current year 2024.

BofA Securities, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $34, previously predicting the price at $31. The rating they have provided for RVMD stocks is “Buy” according to the report published on January 05th, 2024.

Wedbush gave a rating of “Outperform” to RVMD, setting the target price at $41 in the report published on January 04th of the current year.

RVMD Trading at 4.15% from the 50-Day Moving Average

After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.83% of loss for the given period.

Volatility was left at 4.20%, however, over the last 30 days, the volatility rate increased by 3.94%, as shares surge +4.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.98% upper at present.

During the last 5 trading sessions, RVMD rose by +4.63%, which changed the moving average for the period of 200-days by +24.86% in comparison to the 20-day moving average, which settled at $31.63. In addition, Revolution Medicines Inc saw 9.45% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RVMD starting from Cislini Jeff, who sale 1,500 shares at the price of $30.99 back on Mar 27 ’24. After this action, Cislini Jeff now owns 54,374 shares of Revolution Medicines Inc, valued at $46,481 using the latest closing price.

GOLDSMITH MARK A, the of Revolution Medicines Inc, sale 5,788 shares at $31.58 during a trade that took place back on Mar 18 ’24, which means that GOLDSMITH MARK A is holding 460,379 shares at $182,804 based on the most recent closing price.

Stock Fundamentals for RVMD

Current profitability levels for the company are sitting at:

  • -42.07 for the present operating margin
  • 0.2 for the gross margin

The net margin for Revolution Medicines Inc stands at -36.85. The total capital return value is set at -0.25. Equity return is now at value -34.75, with -29.82 for asset returns.

Based on Revolution Medicines Inc (RVMD), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -3.99. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 1607.87.

Currently, EBITDA for the company is -477.88 million with net debt to EBITDA at 1.26. When we switch over and look at the enterprise to sales, we see a ratio of 393.9. The receivables turnover for the company is 9.23for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.06.

Conclusion

In a nutshell, Revolution Medicines Inc (RVMD) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts